Bioequivalence and Bioavailability Forum • CFDA: Draft guidance?

CFDA: Draft guidance? [RSABE / ABEL]

posted by libaiyi – China, 2018-06-13 03:39 – Posting: # 18895
Views: 1,452

Thanks for you reply.

Another question,
how to write the null hypothesis and alternative hypothesis for BE based on FDA or EMA method?

Complete thread:

Calculate the BE limits for HVDPs based on EMA - libaiyi, 2018-06-08 11:41 [RSABE / ABEL]
- Calculate the BE limits for HVDPs based on EMA - Shuanghe, 2018-06-08 12:51
- (Expanded) BE limits, EMA-style - Helmut, 2018-06-08 13:19
  - (Expanded) BE limits, EMA-style - libaiyi, 2018-06-11 07:21
    - CFDA: Yet another story? - Helmut, 2018-06-11 12:24
      - CFDA: Yet another story? - libaiyi, 2018-06-12 11:09
        
        CFDA: Draft guidance? - Helmut, 2018-06-12 14:54
        
        CFDA: Draft guidance? - libaiyi, 2018-06-13 03:39
        
        Hypotheses generated “in face of the data” - Helmut, 2018-06-13 11:39
        
        Hypotheses generated “in face of the data” - libaiyi, 2018-06-14 03:46

Bioequivalence and Bioavailability Forum | Admin contact
19,286 posts in 4,100 threads, 1,317 registered users;
online 9 (1 registered, 8 guests [including 6 identified bots]).

I try not to think with my gut.
If I’m serious about understanding the world,
thinking with anything besides my brain, as tempting as that might be,
is likely to get me into trouble. Carl Sagan

The BIOEQUIVALENCE / BIOAVAILABILITY FORUM is hosted by
BEBAC

BEBAC

Ing. Helmut Schütz